UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496-1506

2002

Volltextzugriff (PDF)

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Multiple sclerosis, 2006-06, Vol.12 (3), p.309-320

2006

Volltextzugriff (PDF)

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

Neurology, 1998-03, Vol.50 (3), p.701-708

1998

Volltextzugriff (PDF)

Influence of infection on exacerbations of multiple sclerosis

Annals of neurology, 1994, Vol.36 (S1), p.S25-S28

Panitch, Hillel S.

1994

Volltextzugriff (PDF)

Developmental changes in chest wall compliance in infancy and early childhood

Journal of applied physiology (1985), 1995-01, Vol.78 (1), p.179-184

1995

Volltextzugriff (PDF)

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134-1140

2008

Volltextzugriff (PDF)

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-08, Vol.6 (4), p.255-266

2000

Volltextzugriff (PDF)

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-04, Vol.6 (4), p.255-266

2000

Volltextzugriff (PDF)

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Neurology, 1994-06, Vol.44 (6), p.1054-1054

1994

Volltextzugriff (PDF)

Bronchiolitis in infants

Current opinion in pediatrics, 2001-06, Vol.13 (3), p.256-260

Panitch, H B

2001

Volltextzugriff (PDF)

Interferons in multiple sclerosis : a review of the evidence

Drugs (New York, N.Y.), 1992-12, Vol.44 (6), p.946-962

PANITCH, H. S

1992

Volltextzugriff (PDF)

Intramedullary spinal cord abscess in a healthy woman

Neurology, 2007-04, Vol.68 (15), p.1230-1230

2007

Volltextzugriff (PDF)

Respiratory Care of the patient with duchenne muscular dystrophy: ATS Consensus statement

American journal of respiratory and critical care medicine, 2004-08, Vol.170 (4), p.456-465

2004

Volltextzugriff (PDF)

Exacerbations of multiple sclerosis in patients treated with gamma interferon

The Lancet (British edition), 1987-04, Vol.1 (8538), p.893-895

1987

Volltextzugriff (PDF)

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Volltextzugriff (PDF)

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Neurology, 2004-11, Vol.63 (10), p.1788-1795

2004

Volltextzugriff (PDF)

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Neurology, 1996-06, Vol.46 (6), p.1639-1643

1996

Volltextzugriff (PDF)

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Chest wall compliance in infants and children with neuromuscular disease

American journal of respiratory and critical care medicine, 1996-10, Vol.154 (4 Pt 1), p.1045-1048

1996

Volltextzugriff (PDF)

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Multiple sclerosis, 1995-11, Vol.1 (3), p.165-169

1995

Volltextzugriff (PDF)

B52 NEONATAL LUNG DISEASE: FROM BENCH TO BABIES: Bethanechol Improves Respiratory Symptoms In Young Children With Tracheomalacia

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Outcomes In Neonates With Bronchopulmonary Dysplasia And Tracheobronchomalacia

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Neurology, 1996-12, Vol.47 (6), p.1457-1462

1996

Volltextzugriff (PDF)

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

Neurology, 2007-10, Vol.69 (14), p.1391-1403

2007

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Aktive Filter

ThemaMultiple Sclerosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(136)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

Influence of infection on exacerbations of multiple sclerosis

Developmental changes in chest wall compliance in infancy and early childhood

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Bronchiolitis in infants

Interferons in multiple sclerosis : a review of the evidence

Intramedullary spinal cord abscess in a healthy woman

Respiratory Care of the patient with duchenne muscular dystrophy: ATS Consensus statement

Exacerbations of multiple sclerosis in patients treated with gamma interferon

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

Chest wall compliance in infants and children with neuromuscular disease

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

B52 NEONATAL LUNG DISEASE: FROM BENCH TO BABIES: Bethanechol Improves Respiratory Symptoms In Young Children With Tracheomalacia

D25 NEONATAL AND CONGENITAL LUNG DISEASES: Outcomes In Neonates With Bronchopulmonary Dysplasia And Tracheobronchomalacia

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

Aktive Filter

Suchergebnisse filtern